Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5346)
All Articles published online
|
Publishing Process of This Article
|
Sep 27, 2021 (publication date) through Oct 31, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mattos ÂZ, Debes JD, Dhanasekaran R, Benhammou JN, Arrese M, Patrício ALV, Zilio AC, Mattos AA. Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge. World J Hepatol 2021; 13(9): 1107-1121 [PMID: 34630878 DOI: 10.4254/wjh.v13.i9.1107] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i9/1107.htm |
| Number | Citing Articles |
| 1 |
Cristiane Valle Tovo, Angelo Zambam de Mattos, Gabriela Perdomo Coral, Giovana D P Sartori, Livia Villela Nogueira, Gustavo Tovo Both, Cristiane A Villela-Nogueira, Angelo A de Mattos. Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis. World Journal of Gastroenterology 2023; 29(2): 343-356 doi: 10.3748/wjg.v29.i2.343
|
| 2 |
Angelo Zambam de Mattos, Isadora Zanotelli Bombassaro, Arndt Vogel, Jose D Debes. Hepatocellular carcinoma-the role of the underlying liver disease in clinical practice. World Journal of Gastroenterology 2024; 30(19): 2488-2495 doi: 10.3748/wjg.v30.i19.2488
|
| 3 |
Marina Farah, Chimaobi Anugwom, Javier Diaz Ferrer, Estefania Liza Baca, Angelo Z. Mattos, João Pedro P. Possebon, Marco Arrese, Jhon Prieto, Domingo Balderramo, Enrique Carrera, Jose D. Debes. Changing epidemiology of hepatocellular carcinoma in South America: A report from the South American liver research network. Annals of Hepatology 2023; 28(2): 100876 doi: 10.1016/j.aohep.2022.100876
|
| 4 |
Jie‐Lun Ku, Jia‐Rou Hsu, Yung‐Tsung Li, Li‐Ling Wu. Interplay among IL1R1, gut microbiota, and bile acids in metabolic dysfunction‐associated steatotic liver disease: a comprehensive review. Journal of Gastroenterology and Hepatology 2024; doi: 10.1111/jgh.16750
|
| 5 |
Avilene Rodríguez-Lara, Ascensión Rueda-Robles, María José Sáez-Lara, Julio Plaza-Diaz, Ana I. Álvarez-Mercado. From Non-Alcoholic Fatty Liver Disease to Liver Cancer: Microbiota and Inflammation as Key Players. Pathogens 2023; 12(7): 940 doi: 10.3390/pathogens12070940
|
| 6 |
Ioana Rusu, Radu Pirlog, Paul Chiroi, Andreea Nutu, Vlad Radu Puia, Alin Cornel Fetti, Daniel Radu Rusu, Ioana Berindan-Neagoe, Nadim Al Hajjar. The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC. International Journal of Molecular Sciences 2022; 23(20): 12370 doi: 10.3390/ijms232012370
|
| 7 |
Arnab Banerjee, Debasmita Das, Sandip Mukherjee, Bithin Kumar Maji. Comprehensive study of the interplay between immunological and metabolic factors in hepatic steatosis. International Immunopharmacology 2024; 133: 112091 doi: 10.1016/j.intimp.2024.112091
|